Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -115.18% is 51% above its 3-year average of -235.24%, near the high end of its 3-year range (-1381.17%–-83.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 67.94% above its 12-month average of -359.24%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -115.18%.
RETURN ON INVESTED CAPITAL (ROIC)
-115.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-359.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-235.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+67.94%
CURRENT VS 3Y AVG
+51.04%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 707 covered companies
CURRENT VS SECTOR MEDIAN
-243.82%
vs the sector median at left
MIRA Pharmaceuticals, Inc.
Market Cap
$30.89M
Return on Invested Capital (ROIC)
-115.18%
TTM Avg
-359.24%
3Y Avg
-235.24%
5Y Avg
N/A
Market Cap
$30.62M
Return on Invested Capital (ROIC)
-15.35%
TTM Avg
-18.43%
3Y Avg
-24.75%
5Y Avg
-44.47%
Market Cap
$30.68M
Return on Invested Capital (ROIC)
-126.84%
TTM Avg
-48.51%
3Y Avg
-88.12%
5Y Avg
-74.86%
Market Cap
$30.32M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-54.98%
3Y Avg
-73.47%
5Y Avg
-75.57%
Market Cap
$31.77M
Return on Invested Capital (ROIC)
3.16%
TTM Avg
0.50%
3Y Avg
4.62%
5Y Avg
2.96%
Market Cap
$31.95M
Return on Invested Capital (ROIC)
-32.68%
TTM Avg
-38.21%
3Y Avg
-33.48%
5Y Avg
-43.06%
Market Cap
$30.09M
Return on Invested Capital (ROIC)
-135.73%
TTM Avg
-98.73%
3Y Avg
-101.28%
5Y Avg
-89.83%
Market Cap
$29.66M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.14M
Return on Invested Capital (ROIC)
-50.66%
TTM Avg
-13.98%
3Y Avg
7.71%
5Y Avg
25.88%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MIRA Pharmaceuticals, Inc. (MIRA) | $30.89M | -115.18% | -359.24% | -235.24% | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.62M | -15.35% | -18.43% | -24.75% | -44.47% |
| Context Therapeutics Inc. (CNTX)vs › | $30.68M | -126.84% | -48.51% | -88.12% | -74.86% |
| BeyondSpring Inc. (BYSI)vs › | $30.32M | N/A | -54.98% | -73.47% | -75.57% |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 3.16% | 0.50% | 4.62% | 2.96% |
| SCYNEXIS, Inc. (SCYX)vs › | $31.95M | -32.68% | -38.21% | -33.48% | -43.06% |
| CervoMed Inc. (CRVO)vs › | $30.09M | -135.73% | -98.73% | -101.28% | -89.83% |
| OneMedNet Corporation (ONMD)vs › | $29.66M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | -50.66% | -13.98% | 7.71% | 25.88% |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -99.36% | -324.14% | -260.84% | -230.57% |
ROIC
-115.2%
ROE
-116.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -115.18% |
| 2026-03-31 | -104.73% |
| 2025-12-31 | -100.98% |
| 2025-09-30 | -94.13% |
| 2025-06-30 | -1381.17% |
| 2025-03-31 | -622.44% |
| 2024-12-31 | -364.51% |
| 2024-09-30 | -241.68% |
| 2024-06-30 | -437.83% |
| 2024-03-31 | -283.67% |
| 2023-12-31 | -194.91% |
| 2023-09-30 | -83.65% |
| 2023-06-30 | -179.14% |
